新京报贝壳财经讯（记者黄鑫宇）针对“3·15”晚会曝光医美外泌体产品违规套证乱象，北交所上市公司山西锦波生物医药股份有限公司（即“锦波生物”，920982.BJ）3月17日发布声明称，被曝光企业的违法行为与锦波生物无任何关联。同时锦波生物呼吁消费者认准三类医疗器械注册证书（即“械注准3”）标识，远离非法注射陷阱。锦波生物称，针对“3·15”晚会曝光的医美行业外泌体产品违规“套证”、非法注射等乱象，...
Source Link新京报贝壳财经讯（记者黄鑫宇）针对“3·15”晚会曝光医美外泌体产品违规套证乱象，北交所上市公司山西锦波生物医药股份有限公司（即“锦波生物”，920982.BJ）3月17日发布声明称，被曝光企业的违法行为与锦波生物无任何关联。同时锦波生物呼吁消费者认准三类医疗器械注册证书（即“械注准3”）标识，远离非法注射陷阱。锦波生物称，针对“3·15”晚会曝光的医美行业外泌体产品违规“套证”、非法注射等乱象，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.